Are We Heading Toward a Recession?
Fears of a recession in 2025 grew at the end…
Sell
27
MRNA Quote, Financials, Valuation and Earnings
Last price:
$24.26
Seasonality move
:
24.17%
Day range:
$24.22 - $25.32
52-week range:
$23.15 - $170.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.01x
P/B ratio:
0.93x
Volume:
7.1M
Avg. volume:
9.9M
1-year change:
-80.23%
Market cap:
$9.4B
Revenue:
$3.2B
EPS (TTM):
-$8.73
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $274M | $17.7B | $18.9B | $6.8B | $3.2B | |
| Revenue Growth (YoY) | 470.83% | 6372.99% | 6.42% | -64.22% | -52.64% | |
| Cost of Revenues | $8M | $2.6B | $5.4B | $4.7B | $1.5B | |
| Gross Profit | $266M | $15.1B | $13.5B | $2.1B | $1.7B | |
| Gross Profit Margin | 97.08% | 85.25% | 71.31% | 30.52% | 54.24% | |
| R&D Expenses | $1.4B | $2B | $3.3B | $4.8B | $4.5B | |
| Selling, General & Admin | $188M | $567M | $1.1B | $1.5B | $1.2B | |
| Other Inc / (Exp) | -$6M | -$29M | -$45M | -$86M | -$63M | |
| Operating Expenses | $1B | $1.8B | $4B | $6.3B | $5.7B | |
| Operating Income | -$763M | $13.3B | $9.4B | -$4.2B | -$3.9B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$744M | $13.3B | $9.6B | -$3.9B | -$3.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3M | $1.1B | $1.2B | $772M | -$46M | |
| Net Income to Company | -$747M | $12.2B | $8.4B | -$4.7B | -$3.6B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$747M | $12.2B | $8.4B | -$4.7B | -$3.6B | |
| Basic EPS (Cont. Ops) | -$1.96 | $30.31 | $21.26 | -$12.33 | -$9.28 | |
| Diluted EPS (Cont. Ops) | -$1.96 | $28.29 | $20.12 | -$12.33 | -$9.28 | |
| Weighted Average Basic Share | $381M | $403M | $394M | $382M | $384M | |
| Weighted Average Diluted Share | $381M | $431M | $416M | $382M | $384M | |
| EBITDA | -$732M | $13.5B | $9.8B | -$3.3B | -$3.4B | |
| EBIT | -$763M | $13.3B | $9.4B | -$3.9B | -$3.6B | |
| Revenue (Reported) | $274M | $17.7B | $18.9B | $6.8B | $3.2B | |
| Operating Income (Reported) | -$763M | $13.3B | $9.4B | -$4.2B | -$3.9B | |
| Operating Income (Adjusted) | -$763M | $13.3B | $9.4B | -$3.9B | -$3.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.7B | $5.9B | $1.8B | $167M | $107M | |
| Revenue Growth (YoY) | 43475% | 240.79% | -69.06% | -90.91% | -35.93% | |
| Cost of Revenues | $193M | $1B | $792M | $96M | $90M | |
| Gross Profit | $1.6B | $4.9B | $1B | $71M | $17M | |
| Gross Profit Margin | 88.93% | 82.88% | 56.91% | 42.52% | 15.89% | |
| R&D Expenses | $401M | $554M | $1.1B | $1.1B | $856M | |
| Selling, General & Admin | $77M | $268M | $305M | $274M | $212M | |
| Other Inc / (Exp) | -$7M | -$7M | -$39M | -$13M | -$3M | |
| Operating Expenses | $284M | $696M | $1.4B | $1.3B | $1.1B | |
| Operating Income | $1.3B | $4.2B | -$366M | -$1.3B | -$1.1B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.3B | $4.2B | -$305M | -$1.2B | -$964M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $39M | $572M | -$384M | $10M | $7M | |
| Net Income to Company | $1.2B | $3.7B | $79M | -$1.2B | -$971M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.2B | $3.7B | $79M | -$1.2B | -$971M | |
| Basic EPS (Cont. Ops) | $3.05 | $9.09 | $0.20 | -$3.07 | -$2.52 | |
| Diluted EPS (Cont. Ops) | $2.84 | $8.58 | $0.19 | -$3.07 | -$2.52 | |
| Weighted Average Basic Share | $400M | $402M | $386M | $382M | $386M | |
| Weighted Average Diluted Share | $430M | $426M | $405M | $382M | $386M | |
| EBITDA | $1.3B | $4.3B | -$218M | -$1.1B | -$924M | |
| EBIT | $1.3B | $4.2B | -$296M | -$1.2B | -$963M | |
| Revenue (Reported) | $1.7B | $5.9B | $1.8B | $167M | $107M | |
| Operating Income (Reported) | $1.3B | $4.2B | -$366M | -$1.3B | -$1.1B | |
| Operating Income (Adjusted) | $1.3B | $4.2B | -$296M | -$1.2B | -$963M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2B | $21.9B | $14.8B | $5.1B | $3.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $3.4B | $5.2B | $4B | $1.5B | |
| Gross Profit | $1.8B | $18.5B | $9.6B | $1.1B | $1.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $1.7B | $2.1B | $3.9B | $4.8B | $4.3B | |
| Selling, General & Admin | $241M | $758M | $1.2B | $1.5B | $1.1B | |
| Other Inc / (Exp) | -$7M | -$29M | -$77M | -$60M | -$53M | |
| Operating Expenses | $1.2B | $2.2B | $4.8B | $6.2B | $5.4B | |
| Operating Income | $634M | $16.3B | $4.8B | -$5.1B | -$3.7B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $640M | $16.3B | $5B | -$4.8B | -$3.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $42M | $1.6B | $257M | $1.2B | -$49M | |
| Net Income to Company | $598M | $14.6B | $4.8B | -$6B | -$3.4B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $598M | $14.6B | $4.8B | -$6B | -$3.4B | |
| Basic EPS (Cont. Ops) | $1.46 | $36.32 | $12.23 | -$15.65 | -$8.73 | |
| Diluted EPS (Cont. Ops) | $1.25 | $34.03 | $11.57 | -$15.67 | -$8.73 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $662M | $16.6B | $5.2B | -$4.2B | -$3.2B | |
| EBIT | $623M | $16.3B | $4.9B | -$4.8B | -$3.4B | |
| Revenue (Reported) | $2B | $21.9B | $14.8B | $5.1B | $3.1B | |
| Operating Income (Reported) | $634M | $16.3B | $4.8B | -$5.1B | -$3.7B | |
| Operating Income (Adjusted) | $623M | $16.3B | $4.9B | -$4.8B | -$3.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.7B | $5.9B | $1.8B | $167M | $107M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $193M | $1B | $792M | $96M | $90M | |
| Gross Profit | $1.6B | $4.9B | $1B | $71M | $17M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $401M | $554M | $1.1B | $1.1B | $856M | |
| Selling, General & Admin | $77M | $268M | $305M | $274M | $212M | |
| Other Inc / (Exp) | -$7M | -$7M | -$39M | -$13M | -$3M | |
| Operating Expenses | $284M | $696M | $1.4B | $1.3B | $1.1B | |
| Operating Income | $1.3B | $4.2B | -$366M | -$1.3B | -$1.1B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.3B | $4.2B | -$305M | -$1.2B | -$964M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $39M | $572M | -$384M | $10M | $7M | |
| Net Income to Company | $1.2B | $3.7B | $79M | -$1.2B | -$971M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.2B | $3.7B | $79M | -$1.2B | -$971M | |
| Basic EPS (Cont. Ops) | $3.05 | $9.09 | $0.20 | -$3.07 | -$2.52 | |
| Diluted EPS (Cont. Ops) | $2.84 | $8.58 | $0.19 | -$3.07 | -$2.52 | |
| Weighted Average Basic Share | $400M | $402M | $386M | $382M | $386M | |
| Weighted Average Diluted Share | $430M | $426M | $405M | $382M | $386M | |
| EBITDA | $1.3B | $4.3B | -$218M | -$1.1B | -$924M | |
| EBIT | $1.3B | $4.2B | -$296M | -$1.2B | -$963M | |
| Revenue (Reported) | $1.7B | $5.9B | $1.8B | $167M | $107M | |
| Operating Income (Reported) | $1.3B | $4.2B | -$366M | -$1.3B | -$1.1B | |
| Operating Income (Adjusted) | $1.3B | $4.2B | -$296M | -$1.2B | -$963M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.6B | $6.8B | $3.2B | $2.9B | $1.9B | |
| Short Term Investments | $2B | $3.9B | $6.7B | $5.7B | $5.1B | |
| Accounts Receivable, Net | $1.4B | $3.2B | $1.4B | $892M | $358M | |
| Inventory | $47M | $1.4B | $949M | $202M | $117M | |
| Prepaid Expenses | $224M | $554M | $851M | $350M | $307M | |
| Other Current Assets | $11M | $26M | $44M | $88M | $58M | |
| Total Current Assets | $6.3B | $16.1B | $13.4B | $10.3B | $8.1B | |
| Property Plant And Equipment | $387M | $1.4B | $2.1B | $2.7B | $3B | |
| Long-Term Investments | $639M | $6.8B | $8.4B | $4.7B | $2.5B | |
| Goodwill | -- | -- | -- | $52M | $52M | |
| Other Intangibles | -- | -- | -- | $44M | $40M | |
| Other Long-Term Assets | $13M | $46M | $946M | $181M | $171M | |
| Total Assets | $7.3B | $24.7B | $25.9B | $18.4B | $14.1B | |
| Accounts Payable | $18M | $302M | $487M | $520M | $405M | |
| Accrued Expenses | $375M | $1.3B | $1.9B | $997M | $745M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $30M | $211M | $196M | $25M | $37M | |
| Other Current Liabilities | $4M | $14M | $53M | $41M | $181M | |
| Total Current Liabilities | $4.4B | $9.1B | $4.9B | $3B | $2.2B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.8B | $10.5B | $6.7B | $4.6B | $3.2B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | $3M | -$24M | -$370M | -$123M | -$10M | |
| Common Equity | $2.6B | $14.1B | $19.1B | $13.9B | $10.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $2.6B | $14.1B | $19.1B | $13.9B | $10.9B | |
| Total Liabilities and Equity | $7.3B | $24.7B | $25.9B | $18.4B | $14.1B | |
| Cash and Short Terms | $4.6B | $10.7B | $9.9B | $8.6B | $7B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $5.4B | $5B | $3.4B | $2.1B | $1.6B | |
| Short Term Investments | $2.3B | $5.1B | $5.5B | $6.5B | $4.4B | |
| Accounts Receivable, Net | $3.2B | $3.2B | $1.1B | $137M | $78M | |
| Inventory | $494M | $1.9B | $732M | $295M | $128M | |
| Prepaid Expenses | $246M | $858M | $882M | $327M | $288M | |
| Other Current Assets | -- | $36M | $64M | $68M | $69M | |
| Total Current Assets | $11.7B | $16.4B | $12.1B | $9.6B | $6.8B | |
| Property Plant And Equipment | $461M | $1.5B | $2.1B | $2.8B | $3B | |
| Long-Term Investments | $468M | $9.2B | $7.5B | $3.7B | $2.4B | |
| Goodwill | -- | -- | $52M | $52M | $52M | |
| Other Intangibles | -- | -- | $48M | $43M | $49M | |
| Other Long-Term Assets | $12M | $94M | $981M | $180M | $150M | |
| Total Assets | $12.7B | $27.6B | $24.1B | $16.7B | $12.7B | |
| Accounts Payable | $8M | $199M | $389M | $183M | $226M | |
| Accrued Expenses | $720M | $1.5B | $1.5B | $727M | $544M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $206M | $181M | $25M | $43M | |
| Other Current Liabilities | $149M | $34M | $31M | $165M | $209M | |
| Total Current Liabilities | $8.4B | $9.2B | $3.5B | $2.4B | $1.6B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $8.9B | $10.5B | $5.3B | $3.9B | $2.6B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | $1M | -$184M | -$267M | -$101M | $10M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $3.8B | $17.1B | $18.9B | $12.8B | $10.1B | |
| Total Liabilities and Equity | $12.7B | $27.6B | $24.1B | $16.7B | $12.7B | |
| Cash and Short Terms | $7.7B | $10.1B | $8.9B | $8.5B | $6B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$747M | $12.2B | $8.4B | -$4.7B | -$3.6B | |
| Depreciation & Amoritzation | $31M | $232M | $348M | $621M | $189M | |
| Stock-Based Compensation | $93M | $142M | $226M | $305M | $429M | |
| Change in Accounts Receivable | -$1.4B | -$1.8B | $1.8B | $493M | $534M | |
| Change in Inventories | -$47M | -$1.4B | $492M | $747M | $83M | |
| Cash From Operations | $2B | $13.6B | $5B | -$3.1B | -$3B | |
| Capital Expenditures | $68M | $284M | $400M | $707M | $1.1B | |
| Cash Acquisitions | -- | -- | -- | -$85M | -- | |
| Cash From Investing | -$1.7B | -$8.5B | -$5.2B | $4.2B | $1.9B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$857M | -$3.3B | -$1.2B | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $2B | -$873M | -$3.4B | -$1.4B | $56M | |
| Beginning Cash (CF) | $248M | $2.6B | $6.9B | $3.2B | $2.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.4B | $4.2B | -$3.6B | -$289M | -$999M | |
| Ending Cash (CF) | $2.6B | $6.9B | $3.2B | $2.9B | $1.9B | |
| Levered Free Cash Flow | $2B | $13.3B | $4.6B | -$3.8B | -$4.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.2B | $3.7B | $79M | -$1.2B | -$971M | |
| Depreciation & Amoritzation | $15M | $79M | $78M | $36M | $39M | |
| Stock-Based Compensation | $30M | $44M | $75M | $101M | $115M | |
| Change in Accounts Receivable | -$1.8B | $1M | $272M | $755M | $280M | |
| Change in Inventories | -$448M | -$501M | $216M | -$93M | -$8M | |
| Cash From Operations | $3B | $2.8B | -$1.2B | -$989M | -$1B | |
| Capital Expenditures | $35M | $132M | $113M | $196M | $127M | |
| Cash Acquisitions | -- | -- | -$85M | -- | -- | |
| Cash From Investing | -$180M | -$3.9B | $2B | $118M | $730M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$2M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$623M | -$526M | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$1M | |
| Cash From Financing | $26M | -$642M | -$542M | $14M | $4M | |
| Beginning Cash (CF) | $2.6B | $6.9B | $3.2B | $2.9B | $1.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.8B | -$1.8B | $244M | -$857M | -$303M | |
| Ending Cash (CF) | $5.5B | $5.1B | $3.5B | $2.1B | $1.6B | |
| Levered Free Cash Flow | $2.9B | $2.6B | -$1.3B | -$1.2B | -$1.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $598M | $14.6B | $4.8B | -$6B | -$3.4B | |
| Depreciation & Amoritzation | $39M | $296M | $347M | $579M | $192M | |
| Stock-Based Compensation | $103M | $156M | $257M | $331M | $443M | |
| Change in Accounts Receivable | -$3.2B | $36M | $2.1B | $976M | $59M | |
| Change in Inventories | -$495M | -$1.4B | $1.2B | $438M | $168M | |
| Cash From Operations | $5.1B | $13.4B | $993M | -$2.9B | -$3.1B | |
| Capital Expenditures | $97M | $381M | $381M | $790M | $982M | |
| Cash Acquisitions | -- | -- | -$85M | -- | -- | |
| Cash From Investing | -$1.5B | -$12.3B | $756M | $2.3B | $2.6B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$1.5B | -$3.2B | -$627M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $1.5B | -$1.5B | -$3.3B | -$821M | $46M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $5B | -$393M | -$1.6B | -$1.4B | -$445M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $5B | $13B | $612M | -$3.7B | -$4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.2B | $3.7B | $79M | -$1.2B | -$971M | |
| Depreciation & Amoritzation | $15M | $79M | $78M | $36M | $39M | |
| Stock-Based Compensation | $30M | $44M | $75M | $101M | $115M | |
| Change in Accounts Receivable | -$1.8B | $1M | $272M | $755M | $280M | |
| Change in Inventories | -$448M | -$501M | $216M | -$93M | -$8M | |
| Cash From Operations | $3B | $2.8B | -$1.2B | -$989M | -$1B | |
| Capital Expenditures | $35M | $132M | $113M | $196M | $127M | |
| Cash Acquisitions | -- | -- | -$85M | -- | -- | |
| Cash From Investing | -$180M | -$3.9B | $2B | $118M | $730M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$2M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$623M | -$526M | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$1M | |
| Cash From Financing | $26M | -$642M | -$542M | $14M | $4M | |
| Beginning Cash (CF) | $2.6B | $6.9B | $3.2B | $2.9B | $1.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.8B | -$1.8B | $244M | -$857M | -$303M | |
| Ending Cash (CF) | $5.5B | $5.1B | $3.5B | $2.1B | $1.6B | |
| Levered Free Cash Flow | $2.9B | $2.6B | -$1.3B | -$1.2B | -$1.2B | |
Get MRNA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MRNA
Sector
P/E ratio
--
23.51x
PEG ratio
--
0.00x
P/B ratio
0.93x
1.65x
Price / LTM sales
3.01x
1.60x
Growth Metrics
MRNA
Sector
Revenue growth
-35.93%
4.92%
Earnings growth
--
7.49%
Revenue (5-year growth)
131.61%
8.25%
Earnings forecast
-$1.85
-$0.20
Profitability
MRNA
Sector
Profitability FY 2024
$1.7B
$53.7M
Return on invested capital
-29.23%
-14.69%
Return on assets
-22.36%
-11.84%
Return on equity
-29.23%
-17.27%
Earnings Date
Last Earnings Date
May
1
Next Earnings Date
Aug
1
Estimated Next Earnings Date
Jul
31
Balance Sheet
MRNA
Sector
Total cash
$6B
$40.3M
Short term investments
$5.1B
$34.6M
Total assets
$14.1B
$119.9M
Long term debt
--
$9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
3 Recession-Proof ETFs to Invest in Now
The U.S. gross domestic product (GDP) contracted 0.3% during the…
Is Butterfly Network the Best Small-Cap Stock?
Brought to public trading by an SPAC merger in early…
Stock Ideas
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 10
Regencell Bioscience Holdings [RGC] is up 79.25% over the past day.
Buy
97
NGVC alert for May 10
Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.
Sell
38
ONTO alert for May 10
Onto Innovation [ONTO] is down 30.17% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
